Senate Bill Would Ban Authorized Generics

Law360, New York (January 31, 2007, 12:00 AM EST) -- A bill was reintroduced in the U.S. Senate Tuesday that would prohibit brand name drug makers from marketing generic versions of their own drugs, a move senators said would improve consumer access to lower-priced drugs.

As anticipated, the senators—John (Jay) D. Rockefeller (D-W.Va.), Charles E. Schumer (D-NY), Patrick Leahy (D-Vt.), and Herb Kohl (D-Wis.)—introduced S.438, the Fair Prescription Drug Competition Act of 2007. The senators, excluding Kohl, introduced the legislation last summer as well.

“As I have said many times, authorized generics are a sham,” Rockefeller...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.